Sunday, November 08, 2009
Dr Reddy's Lipitor
Biotechnology firm Dr Reddy's Laboratories has developed a generic version of Pfizer's Lipitor, the world's largest selling cholesterol-lowering drug. "We have filed an ANDA (abbreviated new drug filing) for atrovastatin and notified Pfizer accordingly," Dr Reddy's told Reuters in response to an email query.
So far, Ranbaxy is the only other Indian drugmaker to develop a generic for the drug, whose U.S. patent expires in 2010. Under a settlement with Pfizer, Ranbaxy has agreed to launch its generic by November 2011.
Reuters
So far, Ranbaxy is the only other Indian drugmaker to develop a generic for the drug, whose U.S. patent expires in 2010. Under a settlement with Pfizer, Ranbaxy has agreed to launch its generic by November 2011.
Reuters
